Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 6, 2002, Pages 1887-1895

  Tsenova, Liana ^a   Mangaliso, Bande ^a   Muller, George ^a   Chen, Yong ^a   Freedman, Victoria H ^a   Stirling, David ^a   Kaplan, Gilla ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 3 AMINOPHTHALIMIDOGLUTARIMIDE; CORTICOSTEROID; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; THALIDOMIDE; THALIDOMIDE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFECT; DRUG POTENTIATION; HISTOLOGY; IMMUNOMODULATION; INFLAMMATION; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; TUBERCULOUS MENINGITIS;

ANIMALS; ANTITUBERCULAR AGENTS; BRAIN; CENTRAL NERVOUS SYSTEM; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MALE; MENINGES; MYCOBACTERIUM BOVIS; RABBITS; THALIDOMIDE; TUBERCULOSIS, MENINGEAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036096363     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.6.1887-1895.2002     Document Type: Article

References (36)

1. Corticosteroids and tuberculosis: Risks and use as adjunct therapy
2. Paradoxical expansive lesions of cerebral tuberculosis during antitubercular drug therapy
3. Effect of thalidomide on the inflammatory response in cerebrospinal fluid in experimental meningitis
4. Corticosteroids in tuberculosis
5. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogs that are potent inhibitors of TNF-alpha
6. Immunomodulation by thalidomide and thalidomide analogs
7. Glucocorticoids in central nervous system bacterial infection
8. Pathology and pathogenetic mechanisms in neurotuberculosis
9. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
10. Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta in the cerebrospinal fluid of children treated for tuberculous meningitis
11. Adjunctive corti-costeroid therapy for tuberculosis: A critical reappraisal of the literature
12. Tuberculosis of the central nervous system in children: A 20-year survey
13. Tuberculosis of the central nervous system
14. Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset
15. Paradoxical response to antitubercular drugs
16. Native organ and species resistance to tuberculosis: Preliminary studies
17. An evaluation of the method of quantitative airborne infection and its use in the study of the pathogenesis of tuberculosis
18. Repeated deterioration of tuberculous meningitis due to a reduction in the corticosteroid dosage during chemotherapy
19. Tuberculous meningitis in children: Clinical features and outcome in 40 cases
20. Treatment
21. Tuberculous meningitis at a large inner-city medical center
22. Steroids for treating tuberculous meningitis
23. Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation
24. Molecular pathophysiology of bacterial meningitis: Current concepts and therapeutic implications
25. Thalidomide therapy in childhood tuberculous meningitis
26. Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess
27. Adjunctive thalidomide therapy of childhood tuberculous meningitis: Possible anti-inflammatory role
28. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis
29. Corticosteroids as adjuvants in the treatment of tuberculosis
30. Tuberculosis of the central nervous system in children
31. Subchronic toxicity of thalidomide in rodents after 13 weeks of oral administration
32. Tuberculous meningitis and co-infection with HIV
33. Experimental tuberculous meningitis
34. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis associated death
35. Tuberculous meningitis in children: Problem to be addressed effectively with thorough contact tracing
36. Friedman-type statistics and consistent multiple comparisons for unbalanced designs